Open Access
Preoperative Autologous Donation Decreases Allogeneic Transfusion but Increases Exposure to All Red Blood Cell Transfusion
TLDR
There is a direct relationship between the transfusion rate in the control group and the benefit derived from preoperative autologous donation, which suggests that other methods of decreasing blood transfusion, such as surgical technique and transfusion protocols, may be as important as preoperative Autologous donated of blood.Abstract:
BACKGROUND
Concern about risks associated with allogeneic red blood cell transfusion has led to interest in methods of decreasing patient exposure to perioperative transfusion.
OBJECTIVE
To perform a meta-analysis to determine the degree to which predonation of autologous blood reduces patients' exposure to allogeneic blood and all transfusions of red blood cells (allogeneic or autologous).
METHODS
We searched MEDLINE, EMBASE, bibliographies, annual reports, press releases, newsletters from organizations with interests in the blood system, and personal files for randomized studies and concurrent control cohort studies in which the control groups were patients excluded for nonmedical reasons.
RESULTS
Patients who predonated autologous blood were less likely to receive allogeneic blood in the 6 randomized studies (n = 933) (odds ratio [OR], 0.17; 95% confidence interval [CI], 0.08-0.32) and in the 9 cohort studies (n = 2351) (OR, 0.19; 95% CI, 0.14-0.26). However, autologous donors were more likely to undergo transfusion with allogeneic and/or autologous blood (for randomized studies: OR, 3.03; 95% CI, 1.70-5.39 and for cohort studies: OR, 12.32; 95% CI, 5.90-25.40). Studies that reported use of transfusion protocols found less benefit with preoperative autologous donation, although the difference was not statistically significant.
CONCLUSIONS
Preoperative autologous donation of blood decreases exposure to allogeneic blood but increases exposure to any transfusion (allogeneic and/or autologous). There is a direct relationship between the transfusion rate in the control group and the benefit derived from preoperative autologous donation. This suggests that other methods of decreasing blood transfusion, such as surgical technique and transfusion protocols, may be as important as preoperative autologous donation of blood.read more
Citations
More filters
Reference EntryDOI
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
David Henry,Paul A. Carless,Annette J Moxey,Dianne L. O'Connell,Barrie Stokes,Dean Fergusson,Katharine Ker +6 more
TL;DR: Data from the head-to-head trials suggest an advantage of aprotinin over the lysine analogues TXA and EACA in terms of reducing perioperative blood loss, but the differences were small.
Journal ArticleDOI
The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials
Regina Kunz,Andrew D Oxman +1 more
TL;DR: On average, failure to use randomisation or adequate concealment of allocation resulted in larger estimates of effect due to a poorer prognosis in non-randomlyselected control groups compared with randomly selected control groups.
Journal ArticleDOI
Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe.
Nadia Rosencher,Hans E. M. Kerkkamp,G. Macheras,L. M. Munuera,G. Menichella,David M. Barton,Saskia Cremers,Ivo Abraham +7 more
TL;DR: The purpose of this study was to assess current practices in blood management in elective orthopedic surgery in Europe and to establish a baseline level of trust in these practices.
Reference EntryDOI
Cell salvage for minimising perioperative allogeneic blood transfusion
TL;DR: The results suggest cell salvage is efficacious in reducing the need for allogeneic red cell transfusion in adult elective cardiac and orthopaedic surgery and the methodological quality of trials was poor.
Journal ArticleDOI
Randomisation to protect against selection bias in healthcare trials.
Jan Odgaard-Jensen,Gunn Elisabeth Vist,Antje Timmer,Regina Kunz,Elie A. Akl,Holger J. Schünemann,Matthias Briel,Alain J Nordmann,Silvia Pregno,Andrew D Oxman +9 more
TL;DR: Comparisons of adequately and inadequately concealed allocation in randomised trials of the same intervention provided high quality evidence that concealment can be crucial in achieving similar treatment groups and, therefore, unbiased estimates of treatment effects.
References
More filters
Journal ArticleDOI
Meta-Analysis in Clinical Trials*
TL;DR: This paper examines eight published reviews each reporting results from several related trials in order to evaluate the efficacy of a certain treatment for a specified medical condition and suggests a simple noniterative procedure for characterizing the distribution of treatment effects in a series of studies.
Journal ArticleDOI
Assessing the quality of reports of randomized clinical trials : is blinding necessary?
Alejandro R. Jadad,R. A. Moore,Dawn Carroll,C. Jenkinson,David Reynolds,David J. Gavaghan,Henry J McQuay +6 more
TL;DR: An instrument to assess the quality of reports of randomized clinical trials (RCTs) in pain research is described and its use to determine the effect of rater blinding on the assessments of quality is described.
Journal ArticleDOI
The Risk of Transfusion-Transmitted Viral Infections
TL;DR: The risk of transmitting the human immunodeficiency virus (HIV), the human T-cell lymphotropic virus (HTLV), the hepatitis C virus (HCV), and the hepatitis B virus (HBV) from screened blood units donated during the window period following a recent, undetected infection is estimated.
Journal ArticleDOI
Effect of anaemia and cardiovascular disease on surgical mortality and morbidity
Jeffrey L. Carson,Amy Duff,Roy M. Poses,Jesse A. Berlin,Richard K. Spence,Richard Trout,Helaine Noveck,Brian L. Strom +7 more
TL;DR: A low preoperative haemoglobin or a substantial operative blood loss increases the risk of death or serious morbidity more in patients with cardiovascular disease than in those without.
Journal ArticleDOI
Bias in Treatment Assignment in Controlled Clinical Trials
TL;DR: Differences in case-fatality rates between treatment and control groups were found, and the importance of keeping those who recruit patients for clinical trials from suspecting which treatment will be assigned to the patient under consideration is emphasized.